What's new

Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 18, Status: Authorised

May 23, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,...

Next Article

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, D...

Related Posts

Human medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

CTIS newsflash - 16 May 2025

May 19, 2025  0